US Pharma MarketingAbbott plans to roll out the device, called Libre Duo 10 Day, later this year. The sensor can measure both glucose and ketones.
Abbott receives FDA nod for dual-analyte sensor
Abbott plans to roll out the device, called Libre Duo 10 Day, later this year. The sensor can measure both glucose and ketones.
Source: MedTech Dive